Nashville, Tennessee 37203


Purpose:

This is an investigational multi-site outcomes registry intended to collect information about a patient's cancer care. Patients may enter the Registry at any time during the patient's current stage in the continuum of care. The registries main objectives will be to measure and evaluate the effects of patient care throughout the care continuum, resulting in the identification of the most effective treatment options. Objectives will encompass evaluations and analytics around safety, effectiveness, and improved efficiencies.


Study summary:

Q


Criteria:

Inclusion Criteria: - 18 or older - Patients that have been diagnosed with/ or are thought to have any form of cancer at any stage in the continuum of their care from screening through survivorship. - Patient must have the ability to understand the nature of the trial and give written informed consent Exclusion Criteria: - There are no exclusion criteria for this Outcomes Registry


NCT ID:

NCT02356822


Primary Contact:

Principal Investigator
Richard Geer, MD
Sarah Cannon

Catherine Howard
Email: catherine.howard@sarahcannon.com


Backup Contact:

N/A


Location Contact:

Nashville, Tennessee 37203
United States

Catherine Howard
Email: catherine.howard@sarahcannon.com

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.